TAMPA, Fla. /PRNewswire/ -- The Amgen Foundation, together with the University of South Florida (USF), today announced the launch of the Amgen Biotech Experience (ABE) program in Tampa, Florida, as part of its long-standing science education program. Globally, ABE is expected to reach nearly 900,000 secondary school students by 2020 in 20 regions around the world.
For nearly 30 years, ABE has empowered high school science teachers to implement real-world biotechnology labs in their classrooms, helping their students better understand science and how it influences their daily lives. The three-week in-class lab initiative provides teacher professional development, instruction materials, and research-grade equipment to classrooms to immerse students in the concepts and techniques scientists use to discover and develop medicines.
The Amgen Foundation's total past and current commitment to ABE is more than $25 million, bringing the Foundation's total commitment to STEM education to nearly $150 million globally.
"The Amgen Biotech Experience has proven its impact in communities around the world. We are excited to see how ABE will transform the learning experience and build curiosity and confidence in science for students in Tampa," said Gwen Cummings, site lead, Amgen Capability Center. "Our goal is to ignite their interest in science and career possibilities. The scientific literacy they gain from this program will serve them well throughout their lives—that's the value of ABE. Amgen is new to Tampa and the Amgen Foundation's investment in the University of South Florida and Hillsborough County Public Schools is one way we are demonstrating our commitment to this vibrant community."
Results of an independent and rigorous evaluation by WestEd found that ABE students have shown significant and substantial gains in biotechnology learning, as well as increased confidence and interest in doing science and biotechnology. Results show that:
Separately, WestEd has also distinguished ABE with the highest possible ranking in STEMworks, its database of effective STEM education programs. Business leaders, funders and STEM advocates use STEMworks to find proven, scalable programs to help them maximize their impact on STEM education.
USF will serve as the program site for ABE in the Tampa area, administering the program to local high schools. "Engagement with science practices is key to improving students' science literacy," said Luanna Prevost, assistant professor, Integrative Biology Department, USF and ABE Tampa site director. "USF is excited to begin this partnership with the Amgen Foundation and bring this hands-on experience to local high school students and teachers."
In the Tampa Bay area, during its initial pilot year, ABE is expected to engage students and teachers at six Hillsborough County schools during this academic year. In 2017, the Amgen Foundation announced ABE's expansion to Australia, Canada, China, France, Germany, Hong Kong SAR, Italy, Netherlands and Singapore. The program is already underway in multiple locations across the United States, Puerto Rico, United Kingdom and Ireland.
About the University of South Florida
The University of South Florida, established in 1956 and located in Tampa, is a high-impact global research university dedicated to student success. The USF System includes three separately accredited institutions: USF, USF St. Petersburg and USF Sarasota-Manatee. Serving more than 50,000 students, the USF System has an annual budget of $1.8 billionand an annual economic impact of $4.4 billion. USF ranks in the top 25 nationally for research expenditures among public universities, according to the National Science Foundation. In 2018, the Florida Board of Governors designated USF as a Preeminent State Research University, placing USF in the most elite category among the state's 12 public universities. USF is a member of the American Athletic Conference.
CONTACT: Amgen, Tampa
Felicia Harvey, 813-334-3462 (media)
University of South Florida
Althea Paul, 813-974-1665
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.